v3.25.4
Transition Period Comparative Data - Schedule of Statements of Operations (Details) - Transition Period [Member] - USD ($)
6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating expenses    
Research and development $ 2,858,566 $ 558,925
General and administrative 1,568,398 2,332,196
Total operating expenses 4,426,964 2,891,121
Loss from Operations (4,426,964) (2,891,121)
Loss before income taxes (4,426,964) (2,891,121)
Income taxes provision (63)
Net loss $ (4,427,027) $ (2,891,121)
Net loss applicable to common stock per share, basic (in Dollars per share) $ (0.12) $ (0.16)
Net loss applicable to common stock per share, diluted (in Dollars per share) $ (0.12) $ (0.16)
Weighted average common stock outstanding, basic (in Shares) 36,515,688 18,126,944
Weighted average common stock outstanding, diluted (in Shares) 36,515,688 18,126,944